The Asia Pacific Artificial Intelligence In Precision Medicine Market would witness market growth of 33.6% CAGR during the forecast period (2022-2028).
Clinical decision assistance and image analysis are currently AI's most prevalent uses in medical settings. By giving them quick access to information or research that is pertinent to their patient, clinical decision support systems assist physicians in making decisions about treatments, drugs, mental health, and other patient requirements.
AI technologies are being used to analyze CT scans, x-rays, MRIs, and other pictures in the field of medical imaging in order to look for lesions or other findings that a human radiologist would overlook.
Precision medicine, also referred to as "personalized medicine," is a cutting-edge strategy for customizing illness prevention and treatment that considers variations in people's genes, lifestyles, and environments. Targeting the appropriate medications to the appropriate patients at the appropriate times is the aim of precision medicine.
Modern medical technologies and procedures are at the cutting edge in several areas in Japan. Japan is a crucial export market for American pharmaceuticals and the third-largest pharmaceutical market in the world. The healthcare sector has been marketed by the Government of Japan ("GOJ") since 2013 as a key growth driver under the nation's economic revival and growth strategy. The pharmaceutical industry in Japan, along with the healthcare industry, has recently attracted new interest.
The China market dominated the Asia Pacific Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $509.1 Million by 2028.The Japan market is estimated to grow a CAGR of 32.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 34.4% during (2022 - 2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Artificial Intelligence In Precision Medicine Market is Projected to reach USD 6.3 Billion by 2028, at a CAGR of 32.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
By Application
By Component
By Technology
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
